NOS3 and endothelial dysfunction: Evidence for the role of several mediators (as endothelial nitric oxide synthase (eNOS), NADPH etc.)in the pathogenesis of doxorubicin-induced endothelial dysfunction has already been proposed in previous studies [10], [25], [33].